These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35566712)

  • 21. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
    Regnery S; Leiner L; Buchele C; Hoegen P; Sandrini E; Held T; Deng M; Eichkorn T; Rippke C; Renkamp CK; König L; Lang K; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2023 May; 18(1):92. PubMed ID: 37248504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-guided stereotactic radiation therapy for head and neck cancers.
    Wang H; Yang J; Lee A; Phan J; Lim TY; Fuller CD; Han EY; Rhee DJ; Salzillo T; Zhao Y; Chopra N; Pham M; Castillo P; Sobremonte A; Moreno AC; Reddy JP; Rosenthal D; Garden AS; Wang X
    Clin Transl Radiat Oncol; 2024 May; 46():100760. PubMed ID: 38510980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk.
    Hoegen P; Katsigiannopulos E; Buchele C; Regnery S; Weykamp F; Sandrini E; Ristau J; Liermann J; Meixner E; Forster T; Renkamp CK; Schlüter F; Rippke C; Debus J; Klüter S; Hörner-Rieber J
    Clin Transl Radiat Oncol; 2023 Mar; 39():100567. PubMed ID: 36935853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar.
    Mazzarotto R; Simoni N; Guariglia S; Rossi G; Micera R; De Robertis R; Pierelli A; Zivelonghi E; Malleo G; Paiella S; Salvia R; Cavedon C; Milella M; Bassi C
    Front Oncol; 2020; 10():600940. PubMed ID: 33392093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric Feasibility of Utilizing the ViewRay Magnetic Resonance Guided Linac System for Image-guided Spine Stereotactic Body Radiation Therapy.
    Redler G; Stevens T; Cammin J; Malin M; Green O; Mutic S; Pitroda S; Aydogan B
    Cureus; 2019 Dec; 11(12):e6364. PubMed ID: 31938646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.
    Wang S; Zheng D; Lin C; Lei Y; Verma V; Smith A; Ma R; Enke CA; Zhou S
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819851520. PubMed ID: 31195891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
    Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric comparison of two treatment planning systems for spine SBRT.
    Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
    Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
    Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
    Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
    de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
    Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.
    Weykamp F; Katsigiannopulos E; Piskorski L; Regnery S; Hoegen P; Ristau J; Renkamp CK; Liermann J; Forster T; Lang K; König L; Rippke C; Buchele C; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Intensity Modulated Radiotherapy Treatment Plans Between 1.5T MR-Linac and Conventional Linac.
    Ding S; Li Y; Liu H; Li R; Wang B; Zhang J; Chen Y; Huang X
    Technol Cancer Res Treat; 2021; 20():1533033820985871. PubMed ID: 33472549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a ⁶⁰Co Magnetic Resonance Image Guidance Radiation Therapy System.
    Wooten HO; Green O; Yang M; DeWees T; Kashani R; Olsen J; Michalski J; Yang D; Tanderup K; Hu Y; Li HH; Mutic S
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):771-8. PubMed ID: 26104932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
    Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
    Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
    Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
    Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.